Combo therapy of vitamin E, selenium, soy doesn’t prevent prostate cancer
Thursday, April 30th, 2009 Posted in prostate cancer prevention | No Comments »A new study, conducted by Canadian researchers, has found that the combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer. The findings were presented at the 104th Annual ...
Prostate cancer ADT increases risk of fractures and cardiovascular-related death
Wednesday, April 29th, 2009 Posted in hormone therapy | No Comments »While medical treatments that decrease testosterone levels—called androgen deprivation therapy (ADT)—are important and effective therapies for men with prostate cancer, they can cause a variety of side effects including skeletal and cardiovascular complications, sexual dysfunction, periodontal disease, and mood disorders. Published ...
Bone density may help predict prostate cancer risk
Tuesday, April 28th, 2009 Posted in prostate cancer risks | No Comments »A new study by Johns Hopkins researchers has found that men with denser bones may be more likely to develop prostate cancer Additionally, bone density may reflect sex hormone levels in men, which can also affect prostate cancer development. "We don't have ...
Doctors urge baseline test for prostate cancer
Monday, April 27th, 2009 Posted in prostate cancer diagnosis | No Comments »An influential doctors group is backing off its call for annual tests after age 50 to screen for prostate cancer. The urology group's new advice says men should be offered a baseline PSA test at age 40, and follow-ups at intervals ...
Pomegranate juice could help prevent prostate cancer recurrence
Monday, April 27th, 2009 Posted in alternative treatments | No Comments »Men involved in the study experienced a significant increase in PSA doubling time following treatment, from a mean of 15.4 months to 60 months, researchers said. "This study suggests that pomegranate juice may effectively slow the progression of prostate cancer after unsuccessful ...
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
Monday, April 27th, 2009 Posted in prostate cancer diagnosis | No Comments »Researchers at Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York, have reviewed current applications of PSA-related data to improve prediction of risk, detection, and prediction of clinical endpoints of prostate cancer treatments. They note that no specific PSA cut-point ...
Statins prevent prostate cancer and reduce the risk of erectile dysfunction
Sunday, April 26th, 2009 Posted in prostate cancer prevention | No Comments »Several recent studies suggest statins help reduce the risk of erectile dysfunction and prevent prostate cancer. All conclusions were to be reported Sunday in Chicago at the American Urological Association's (AUA) annual meeting. A study at the University of Toronto Medical Center in Ontario, ...
The adverse events of androgen deprivation therapy
Saturday, April 25th, 2009 Posted in hormone therapy | No Comments »A new study at Cleveland Clinic, Ohio, has provided yet another review on the adverse events associated with long-term androgen deprivation therapy for the management of progressive and/or advanced prostate cancer. Despite the existing data supporting the use of androgen deprivation ...
UAMS Doctor Performs First-of-its-Kind Surgery
Saturday, April 25th, 2009 Posted in prostate related | No Comments »Medical history has been made at a Little Rock teaching hospital. University of Arkansas for Medical Sciences (UAMS) surgeon Rabii Madi, M.D. has become the first in the nation to perform a double robotic surgery. Dr. Madi removed a patient’s cancerous kidney ...
The evolving potential of targeted focal therapy
Friday, April 24th, 2009 Posted in hifu, prostate cryotherapy | No Comments »A recent study at University of Colorado has summarized available data on the potential roles of targeted focal therapy (TFT) using cryotherapy or high intensity focused ultrasound (HIFU) as an alternate treatment for low-risk prostate cancers. TFT uses 3D mapping biopsies ...